JAY T. FLATLEY

PRESIDENT & CHIEF EXECUTIVE OFFICER, ILLUMINA

Jay was appointed President and CEO of Illumina in 1999, and has taken the company from $1.3 million in sales in 2000 to over $1 billion in 2011, representing a compound annual growth rate in excess of 90%. He oversaw the company’s expansion into the whole genome sequencing area with the acquisition of Solexa in 2006, and more recently into diagnostics and consumer sequencing. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Prior to joining Molecular Dynamics, Jay was Vice President of engineering and strategic planning for Plexus Computers, a manufacturer of high-performance Unix super-microcomputers. Before his career at Plexus, Jay was Executive Vice President for Manning Technologies and held various manufacturing positions while working for the Autolab division of Spectra Physics. Currently, he is a trustee of the Keck Graduate Institute of Applied Life Sciences and a member of the Board of Directors at Illumina, Inc and at Coherent, Inc. Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.